基于的被动免疫疗法用于病变
Francesco Panza1, Vincenzo Solfrizzi2, Antonio Daniele3
1Unit of Research Methodology and Data Sciences for Population Health, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, Castellana Grotte, Bari, Italy.
Handbook of clinical neurology
|August 24, 2023
概括
开发用于治疗包括阿尔茨海默氏症 (AD) 在内的多病症的疾病修饰药物仍然具有挑战性. 目前的研究重点是针对tau的被动免疫疗法,在对初级和二级tau病变的临床试验中,有几种抗tau抗体.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 病是一种复杂的神经疾病,其特征是异常的蛋白聚合.
- 在开发用于治疗包括阿尔茨海默病 (AD) 在内的初级和二级病的有效修改疾病的治疗方法方面取得了有限的进展.
- 现有的病症的症状治疗方法的疗效有限.
结论:
- 被动免疫疗法代表了治疗病的有希望的途径.
- 目前正在进行的I/II期试验将为这些新型免疫治疗药物的疗效提供进一步证据.
- 进一步的研究和临床开发对于推进病治疗至关重要.
相关概念视频
Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556


